U.S. NIPT Test Market Research Report, Top Key Players, and Industry Statistics, 2023-2031

The non-invasive prenatal testing (NIPT) market in the United States is expected to reach USD 2,653 million by 2031. The market is expected to register a CAGR of more than 13% in the forecast period.
DELHI, India - June 9, 2023 - PRLog -- This Well-Versed and Comprehensive United States Non-Invasive Prenatal Testing (NIPT) Market Research Report 2023 is Divided into 14 Chapters:

Chapter 1
contains a brief description of the market under study

Chapter 2 describes the research methodology of the study

Chapter 3 identifies key trends and prospects for the U.S. non-invasive prenatal testing (NIPT) market and draws key conclusions

Chapter 4 analysis of average risk and high-risk non–invasive prenatal testing volume (number of tests performed) and projection through 2031

Chapter 5 evaluates the potential number of NIPT tests performed in the United States with eight years forecast

Chapter 6 discusses the market scenario for non-invasive prenatal testing (NIPT) in the United States in terms of historical market values and projections through 2031

Chapter 7 assessment of market potential and opportunities for this innovation-driven united states non–invasive prenatal testing market with eight years forecast

Chapter 8 highlights key market dynamics in the U.S. NIPT tests market, including factors driving the market, prevailing barriers, potential opportunities, and future trends. This section also includes an analysis of the impact of the driving and restraining factors

Chapter 9 includes a comprehensive analysis of 7 non–invasive prenatal testing comparative analysis

Chapter 10 characteristics of reimbursement structures in the non–invasive prenatal testing market in the United States

Chapter 11 detailed insights into the regulatory framework of the U.S. non–invasive prenatal testing market

Chapter 12 tracks competitive developments, approaches, recent industry developments, and mergers and acquisitions, collaboration, venture capital investment, distribution, exclusivity, partnership and licensing agreements.

Chapter 13 provides the industry landscape and detailed profiles of key companies operating in the non–invasive prenatal testing market in the United States. The companies have been profiled based on their key facts, business description, products and services, current NIPT test portfolio, and key developments.

Chapter 14 i.e. the appendix contains a brief overview of the company, a glossary, contact information, and the disclaimer section.

Key Players in the United States Non–Invasive Prenatal Testing Market are Listed Below:
  • Illumina, Inc.
  • Natera, Inc.
  • Quest Diagnostics
  • Myriad Genetics, Inc.
  • Centogene
  • GenPath
  • PerkinElmer
  • Yourgene Health
  • Invitae Corporation
  • Agilent Technologies
  • Ariosa Diagnostics (Roche)
  • Laboratory Corporation of America Holdings(Labcorp)
More Details @ https://dpiresearch.com/united-states-non-invasive-prenat...

Media Contact
Maria Rai
Source: » Follow
Email:***@dpiresearch.com Email Verified
Tags:Market Share
Location:Delhi - Delhi - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse

Like PRLog?
Click to Share